HistoSonics
Develops non-invasive sonic beam therapy for destroying targeted tumors.
Company facts
- Founded
- 2009
- Employees
- 357
- Headquarters
- United States
- Type
- Private
- Funding
- Series E · $250M · 2025
Open positions
Senior Software Systems Analyst
Sr. Software Systems Analyst at HistoSonics, a medtech company developing the Edison histotripsy system for non-invasive tumor treatment. The role bridges business stakeholders and developers — gathering, analyzing, and documenting software requirements and specs for regulated medical-device software. Hybrid in Plymouth, MN or Ann Arbor, MI.
Sr. Supplier Quality Engineer
HistoSonics is a commercial-stage medtech company advancing the Edison® System, a novel non-invasive sonic beam therapy based on histotripsy. Since receiving FDA De Novo grant for the non-invasive destruction of liver…
Sr. Manager, Service Engineering
HistoSonics is a commercial-stage medtech company advancing the Edison® System, a novel non-invasive sonic beam therapy based on histotripsy. Since receiving FDA De Novo grant for the non-invasive destruction of liver…
Sr. Manager – AI and R&D Infrastructure
HistoSonics is a commercial-stage medtech company advancing the Edison® System, a novel non-invasive sonic beam therapy based on histotripsy. Since receiving FDA De Novo grant for the non-invasive destruction of liver…